LymphoQuant® B-cell Internal Control
LymphoQuant B-cell Internal Controls may be spiked into specimens to estimate the respective number of IGH clonotype equivalents present. Addition o...
LymphoQuant® T-Cell Internal Control
The T-cell LymphoQuant Internal Control and T-cell LymphoTrack Low Positive Control are utilized in controlled MRD studies of TRG and TRB gene rearran...
LymphoTrack® B-cell Low Positive Control
Minimal Residual Disease (MRD) testing by Next-Generation Sequencing (NGS) is a proven tool in the development of management strategies for hematologi...
LymphoTrack® T-Cell Low Positive Control
End User License Agreement
CAREFULLY READ THE TERMS OF THIS END USER LICENSE AGREEMENT BETWEEN YOU AND INVIVOSCRIBE, INC., A CALIFORNIA CORPORATION (“LICENSOR”) BEFORE ACCESSING OR USING Invivoscribe Software (THE “PRODUCT”). BY ACCESSING OR USING THE PRODUCT, OR CLICKING BELOW TO ACKNOWLEDGE YOUR ACCEPTANCE OF THE TERMS AND CONDITIONS OF THIS AGREEMENT, YOU, AS THE USER OF THE PRODUCT, IN WHATEVER CAPACITY (EACH AN “AUTHORIZED USER”), AGREE TO THE TERMS OF THIS AGREEMENT. IF YOU DO NOT AGREE TO ALL OF THE TERMS OF THIS AGREEMENT, DO NOT ACCESS OR USE THE PRODUCT, OR CLICK BELOW TO ACKNOWLEDGE YOUR ACCEPTANCE OF THE TERMS AND CONDITIONS OF THIS AGREEMENT. BY USING THE PRODUCT, YOU ASSERT THAT YOU ARE AN AUTHORIZED REPRESENTATIVE OF THE END USER WITH AUTHORITY TO ENTER INTO THIS AGREEMENT.
This End User License Agreement (“Agreement”) is made and entered into by and between INVIVOSCRIBE, INC., a California corporation (“Licensor”) and You (either an individual or a legal entity), the “Licensee,” as defined herein for the licensing and usage of the Licensor’s software. Licensee acknowledges and agrees that Licensee’s right to use the software in any manner shall be controlled by this Agreement and that such use shall be strictly in accordance with the terms and conditions of this Agreement.
©2022 Invivoscribe, Inc. All rights reserved. The trademarks mentioned herein are the property of Invivoscribe, Inc. and/or its affiliates, or (as to the trademarks of others used herein) their respective owners.
Please fill out the form below, and we will respond within 24 hours during a normal business week.
Or call +1 866.623.8105 to speak with an Invivoscribe Representative.